Dan Riskin
Also known as Daniel Riskin
Dan Riskin is a surgeon and healthcare AI researcher who applies artificial intelligence to clinical records and real-world evidence. During his UCLA surgical residency, he developed medical devices and received an Innovators Under 35 honor in 2005. He co-founded Health Fidelity, which launched REVEAL, a cloud-based clinical natural-language-processing service, in 2012. His research includes studies applying AI to migraine and asthma data in electronic health records. As of October 2026, he is Verantos' founder and CEO, a Clinical Professor of Surgery at Stanford University, and a member of HITAC through December 2026.
- Now at
- Verantos, Stanford University and Health Information Technology Advisory Committee
- Works
- 34
- Citations
- 929
- h-index
- 11
Publication numbers from OpenAlex, as of 19 October 2026.
Timeline
-
2005
Medical-device work at UCLA
He develops medical devices for wound closure and early heart-attack intervention while training as a surgical resident at UCLA; Innovators Under 35 recognizes this work in 2005. His medical studies include Boston University and Tufts, and he enrolls in MIT Sloan's MBA program.
-
2012
Health Fidelity launches REVEAL
At Health Fidelity, he serves as CEO and co-founder when the company launches REVEAL Version 1.1 in 2012, a cloud-based clinical NLP service that turns unstructured narratives into structured, coded information for healthcare applications.
-
2023
AI for migraine records
A 2023 study he coauthors applies artificial intelligence to unstructured EHR data to identify migraine and associated symptoms and conditions.
-
2025
AI-based asthma study
For asthma features, he coauthors a 2025 study comparing AI processing of unstructured EHR data with traditional structured-data methods; advanced methods reach a 94.7% F1 score.
-
2025
Verantos applies AI to records
At Verantos, he serves as CEO in 2025 while the company applies AI to complete patient records to generate high-validity evidence across therapeutic areas.
-
As of October 2026
CEO, professor and HITAC member
As of October 2026, he is Verantos' founder and CEO and a Clinical Professor of Surgery at Stanford University. He serves on HITAC through December 2026. Verantos' pharmacoepidemiology stack transforms fragmented real-world data into high-validity evidence, automates research workflows, and uses a scalable AI foundation.
Career
- NowHealth Information Technology Advisory CommitteeMember
- Since 2025VerantosCEO and Founder
- Since 2006Stanford UniversityClinical Professor of Surgery
- From 2012Health FidelityCEO and Co-founder
- 2006University of California, Los AngelesSurgical resident
Education
Most-cited works
- Massive Transfusion Protocols: The Role of Aggressive Resuscitation Versus Product Ratio in Mortality Reduction
- Innovation in Surgery
- Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies
- Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative Review
- The ethics of innovation in pediatric surgery
Sources and credits
Photo: We have no published photo of Dan Riskin yet. Send us a free-licensed photo.
- Daniel Riskin | Innovators Under 35
- Health Fidelity REVEAL Version 1.1 Extracts Unstructured Clinical Data
- Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records
- Advanced Approaches to Generating High-validity Real-world Evidence in Asthma
- Verantos Ranked Number 444th Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
- About Verantos: our story and leadership | Verantos
- Dan Riskin | Stanford Medicine
- ONC HITAC Member Profile: Dan Riskin
- HITAC Membership





